Erythropoietin (r-HuEPO) for the treatment of anaemia in patients with multiple myeloma and end-stage renal failure.
作者信息
Svára F, Spicka I, Sulková S, Zabka J
出版信息
Nephrol Dial Transplant. 1995 Dec;10(12):2374-5. doi: 10.1093/ndt/10.12.2374b.
PMID:8808252
Abstract
摘要
相似文献
1
Erythropoietin (r-HuEPO) for the treatment of anaemia in patients with multiple myeloma and end-stage renal failure.促红细胞生成素（重组人促红细胞生成素）用于治疗多发性骨髓瘤和终末期肾衰竭患者的贫血。
Nephrol Dial Transplant. 1995 Dec;10(12):2374-5. doi: 10.1093/ndt/10.12.2374b.
2
r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.重组人促红细胞生成素治疗与多发性骨髓瘤和终末期肾病相关的贫血
Clin Nephrol. 1993 Feb;39(2):113.
3
Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.重组促红细胞生成素在一名血液透析患者多发性骨髓瘤相关性贫血治疗中的应用
Nephrol Dial Transplant. 1994;9(7):876-7.
4
Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.促红细胞生成素对接受血液透析的骨髓瘤患者贫血的影响。
BMJ. 1990 Sep 8;301(6750):476-7. doi: 10.1136/bmj.301.6750.476.
5
Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.重组人促红细胞生成素用于一名多发性骨髓瘤合并终末期肾病患者的治疗
Clin Nephrol. 1992 Mar;37(3):145-7.
6
[Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].重组人促红细胞生成素治疗合并肾衰竭的多发性骨髓瘤贫血
An Med Interna. 1995 Apr;12(4):187-8.
7
The use of erythropoietin to treat anaemia in end-stage renal disease.使用促红细胞生成素治疗终末期肾病中的贫血。
Prof Nurse. 1995 Apr;10(7):448-50.
8
Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.促红细胞生成素替代疗法治疗肾性贫血及其对心血管系统的影响。
Clin Nephrol. 1995 Nov;44 Suppl 1:S56-60.
9
Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.重组人促红细胞生成素治疗慢性肾衰竭（透析前）患者的疗效与耐受性
Nephrol Dial Transplant. 1989;4(9):782-6.
10
Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?促红细胞生成素治疗对接受血液透析的骨髓瘤患者是否安全有效？
Clin Nephrol. 1993 Sep;40(3):176-8.
Zotero 插件